What is NDC 71335-1453?

71335-1453 is the product NDC for Gabapentin, Gabapentin 300 mg/1 capsule, listed with the FDA by Bryant Ranch Prepack. It has 10 package NDCs, shown above in 10- and 11-digit form.

Bryant Ranch Prepack, NDC labeler code 71335. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Gabapentin?

561 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Gabapentin NDC 71335-1453 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)71335-1453Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71335-1453Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
71335-1453-0	7133514530071335145300	20 CAPSULE in 1 BOTTLE (71335-1453-0)Marketed from Dec 10, 2024
71335-1453-1	7133514530171335145301	30 CAPSULE in 1 BOTTLE (71335-1453-1)Marketed from Dec 10, 2024
71335-1453-2	7133514530271335145302	90 CAPSULE in 1 BOTTLE (71335-1453-2)Marketed from Jan 9, 2020
71335-1453-3	7133514530371335145303	60 CAPSULE in 1 BOTTLE (71335-1453-3)Marketed from Dec 10, 2024
71335-1453-4	7133514530471335145304	120 CAPSULE in 1 BOTTLE (71335-1453-4)Marketed from Dec 10, 2024
71335-1453-5	7133514530571335145305	100 CAPSULE in 1 BOTTLE (71335-1453-5)Marketed from Dec 10, 2024
71335-1453-6	7133514530671335145306	28 CAPSULE in 1 BOTTLE (71335-1453-6)Marketed from Dec 10, 2024
71335-1453-7	7133514530771335145307	112 CAPSULE in 1 BOTTLE (71335-1453-7)Marketed from Dec 10, 2024
71335-1453-8	7133514530871335145308	84 CAPSULE in 1 BOTTLE (71335-1453-8)Marketed from Dec 10, 2024
71335-1453-9	7133514530971335145309	180 CAPSULE in 1 BOTTLE (71335-1453-9)Marketed from Dec 10, 2024

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Gabapentin
Generic name (nonproprietary): gabapentin
Active ingredients: Gabapentin — 300 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Bryant Ranch PrepackNDC labeler code 71335
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 090705
Marketing start: Dec 5, 2017
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
Identifiers: Product ID 71335-1453_08797a4f-2579-47ba-a93e-01a5de30f6feSPL ID 08797a4f-2579-47ba-a93e-01a5de30f6feSPL set ID 6e7f602a-2c5f-4651-a228-5fc5bf249205RxCUI 310431UNII 6CW7F3G59X

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471335145300 followed by a unit qualifier and the quantity

Package 71335-1453-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 10, 2024.

Indications (excerpt from the label)

Gabapentin capsules are indicated for: Management of postherpetic neuralgia in adults Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy Gabapentin is indicated for: Postherpetic neuralgia in adults ( 1 ) Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 71335-1453

What is NDC 71335-1453?: 71335-1453 is the product NDC for Gabapentin, Gabapentin 300 mg/1 capsule, listed with the FDA by Bryant Ranch Prepack. It has 10 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Gabapentin.
What is the active ingredient?: Gabapentin.
Who is the labeler?: Bryant Ranch Prepack, NDC labeler code 71335. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Gabapentin?: 561 other product NDCs are listed under this name. See all Gabapentin NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Gabapentin NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Gabapentin	Gabapentin 800 mg/1	TabletOral	St. Mary's Medical Park Pharmacy	60760-943	60760-0943-3060760-0943-90
gabapentin	Gabapentin 300 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4763	70518-4763-00
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	Cardinal Health 107, LLC	55154-0581	55154-0581-00
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	Advanced Rx of Tennessee, LLC	80425-0595	80425-0595-0180425-0595-0280425-0595-03+1 more
Gabapentin	Gabapentin 300 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4746	70518-4746-0070518-4746-0170518-4746-02+1 more
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4742	70518-4742-0070518-4742-02
Gabapentin	Gabapentin 400 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4740	70518-4740-00
Gabapentin	Gabapentin 300 mg/1	CapsuleOral	Cardinal Health 107, LLC	55154-0580	55154-0580-00
Gabapentin	Gabapentin 600 mg/1	Tablet, CoatedOral	Coupler LLC	67046-1233	67046-1233-03
Gabapentin	Gabapentin 200 mg/1	CapsuleOral	Trifluent Pharma, LLC	73352-231	73352-0231-01

All 562 Gabapentin NDCs

Other NDCs under ANDA 090705

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 090705
Product	Strength	Form · route	Labeler	Product NDC
Gabapentin	Gabapentin 300 mg/1	CapsuleOral	Cipla USA Inc.	69097-943
Gabapentin	Gabapentin 300 mg/1	CapsuleOral	Asclemed USA, Inc.	76420-020
Gabapentin	Gabapentin 400 mg/1	CapsuleOral	Aphena Pharma Solutions - Tennessee, LLC	71610-166
Gabapentin	Gabapentin 300 mg/1	CapsuleOral	Aphena Pharma Solutions - Tennessee, LLC	71610-185
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	Bryant Ranch Prepack	71335-0073
Gabapentin	Gabapentin 400 mg/1	CapsuleOral	Proficient Rx LP	63187-909
Gabapentin	Gabapentin 300 mg/1	CapsuleOral	Exelan Pharmaceuticals, Inc.	76282-627
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4261
Gabapentin	Gabapentin 400 mg/1	CapsuleOral	Cipla USA Inc.	69097-815
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	Cipla USA Inc.	69097-813
Gabapentin	Gabapentin 300 mg/1	CapsuleOral	Bryant Ranch Prepack	71335-1454
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	Proficient Rx LP	63187-392
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	Exelan Pharmaceuticals, Inc.	76282-321
Gabapentin	Gabapentin 400 mg/1	CapsuleOral	Exelan Pharmaceuticals, Inc.	76282-323